Less Common Pulmonary Diseases Flashcards

(68 cards)

1
Q

Diameter of wall for classification of a cyst

A

<2 mm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

5 major types of diffuse cystic lung disease

A

LAM, PLCH, BHD, LIP, amyloidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

CT findings in LAM

A

diffuse cystic disease with normal intervening parenchyma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Diagnostic criteria for LAM

A

Characteristic CT findings and 1 of the following (biopsy showing LAM, renal angiomyolipomas, chylothorax, tuberous sclerosis complex, high serum VEGF-D level > 800)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Management of LAM

A

Sirolimus (rapamycin), supportive, lung transplant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Cell proliferation causing LAM

A

HMB-45+ (LAM cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Two inheritance patterns of LAM

A

Sporadic and TSC related gene mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Characteristic individual with PLCH

A

young adult smokers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cells found in lesions with PLCH

A

CD1a+, langerin+ CD207

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Mutation associated with PLCH

A

BRAF-V600E

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

2 extrapulmonary diseases associated with PLCH

A

Bone lesions and Diabetes Insipidus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

HRCT findings in PLCH

A

Irregular cysts with basilar sparing, nodules +/- cavidation, reticular opacities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Diagnostic criteria for PLCH

A

Characteristic CT findings with BAL >5% CD1A cells or biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Management of PLCH

A

Stop smoking, 2-chlorodeoxyadenosine (2-CdA, cladribine), BRAF inhibitors (vemurafenib) if BRAF mutation, Steroids, Transplant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Inheritance of BHD

A

autosomal dominant, phenotype variable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Genes and chromosome associated with BHD

A

BHD (FLCN) gene on chromosome 17p11.2, tumor-suppressor protein gene, folliculin gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

2 extrapulmonary findings in BHD

A

Fibrofolliculomas and renal tumors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Diagnostic criteria for BHD

A

Cystic disease with any of the following (family hx of BHD, characteristic skin lesions, renal tumors, or gene testing)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Treatment of BHD

A

Management of pneumothorax, life-long surveillance for kidney tumors, no specific therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Disease characterized by monoclonal plasma cell proliferation localized to the lung

A

Pulmonary Light Chain Deposition Disease (LCDD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Substance secreted by macrophages in PLCDD that causes elastolysis and cyst formation

A

metalloproteinases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Diagnostic criteria for PLCDD

A

Biopsy showing non-amyloid deposits in the alveoli and small airways (no beta pleated sheets and negative congo red staining)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Treatment for PLCDD

A

Chemotherapy and HSCT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

HRCT findings in PLCDD

A

cysts with nodules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Histopathologic findings in Follicular bronchiolitis
Hyperplastic lymphoid follicles with reactive germinal centers along bronchovascular bundles
26
HRCT findings in follicular bronchiolitis
Small nodules with patchy ground-glass opacities and occasional cysts
27
Diseases associated with follicular bronchiolitis
CTDs, immunodeficiency, infections, hypersensitivity reactions
28
2 rare inheritable causes of lung cysts
Neurofibromatosis type 1 (NF1) and Marfan syndrome
29
Disease characterized by accumulation of lipoproteinaceaous material in the alveoli
Pulmonary alveolar proteinosis (PAP)
30
Most common cause of PAP
autoimmune (90%) disruption of GM-CSF signaling leading to impaired surfactant metabolism by macrophages
31
Labs and antibodies elevated in PAP
Serum LDH, surfactant A and D, KL-6, anti-GM-CSF in serum and BAL
32
HRCT findings in PAP
GGO and/or consolidative opacities, patchy or diffuse with sharp demarcation from normal lung (Crazy Paving)
33
Treatment of PAP
Whole lung lavage (supportive care only if mild), GM-CSF replacement, rituximab, statin
34
Disease characterized by extensive intraalveolar deposition of concentrically lamellated calcium phosphate spheres
Pulmonary alveolar microlithiasis
35
Inheritance pattern and gene associated with pulmonary alveolar microlithiasis
Autosomal recessive, SLC34A2 gene
36
Mechanism behind pulmonary alveolar microlithiasis
SLC34A2 gene mutation leads to lack of type IIb sodium phosphate cotransporter in the lungs, leads to abnormal phosphorus metabolism by type II cells causing calcium phosphate microliths
37
Treatment for pulmonary alveolar microlithiasis
none, lung transplant
38
HRCT findings in pulmonary alveolar microlithiasis
"Sandstorm" appearence of parenchyma with black pleural line
39
Rare disease characterized by foamy CD1a negative histiocytes, fibrosis, and osteosclerotic lesions of long bones
Erdheim-Chester Disease
40
Management of Erdheim-Chester Disease
BRAF inhibitors (vemurafenib), interferon-alpha, chemo
41
Rare disorder characterized by diffuse lymphatic proliferation in the lungs
Diffuse pulmonary lymphangiomatosis
42
HRCT findings in diffuse pulmonary lymphangiomatosis
Diffuse interlobular septal thickening, patchy GGO, mediastinal infiltration, and pleural thickening/effusion
43
Treatment of Diffuse pulmonary lymphangiomatosis
sirolimus, bevacizumab
44
Most common form of amyloidosis
AL
45
Two different patterns of parenchymal amyloidosis
Nodules (amyloidomas) or diffuse infiltrates with septal thickening
46
Diagnosis of pulmonary amyloidosis
biopsy material showing apple-green birefringence with polarized light on congo red staining
47
Treatment of trachobronchial amyloidosis
Bronchoscopic laser, external beam therapy
48
Treatment of diffuse parenchymal amyloidosis
treat underlying plasma cell dyscrasia
49
Disease characterized by lymphoplasmacytic infiltrate of IgG4 plasma cells and fibrosis
IgG4 related disease
50
Diagnosis requirements of IgG4RD
2 out of 3 (dense lymphoplasmacytic infiltrate, storiform fibrosis, obliterative phlebitis), or High IgG4 level with clinical symptoms
51
Treatment of IgG4RD
30-60 mg/day of prednisone then taper over weeks to months, rituximab
52
Timing post radiation for radiation pneumonitis
4-12 weeks
53
Timing post radiation for radiation fibrosis
6-12 months
54
Treatment of radiation pneumonitis
40-60 mg/day prednisone x 2 weeks, then taper over 4-12 weeks
55
Disease characterized by congenital pulmonary manifestation with anomalous systemic arterial supply from the aorta
Bronchopulmonary sequestration
56
Raoof article differential for true cysts that are subpleural
Bullae, paraseptal emphysema, honeycombing
57
Raoof article differential for true cysts that are intraparenchymal and associated with GGO
PCP pneumonia, DIP
58
Raoof article differential for true cysts that are intraparenchymal with nodules on CT
LIP, PLCH, Light chain deposition disease, AMyloidosis
59
Raoof article differential for true cysts that are intraparenchymal, no other CT findings, and are solitary or incidental
Incidental cyst, pneumatocele, bronchogenic cyst
60
Raoof article differential for true cysts that are intraparenchymal, no other CT findings, and diffuse/multiple found
BHD, LIP, Malignancy, Infection, LAM, PLCH, tracheobronchial papillomatosis
61
Cystic lung disease associated with * Lower lobe predominant * Elongated * Subpleural and paramediastinal * Associated with a 24% pneumothorax risk
Birt Hogg Dube
62
Fibrofolliculomas in birt hogg dube
63
Cystic lung disease associated with * Round cysts * Diffuse involvement including _juxtaphrenic recesses_ * Intervening normal lung * Chylous effusions * Effects women of childbearing age * Renal angiomyolipomas
LAM
64
Cystic lung disease associated with * Cysts with nodular walls * Pathcy opacities and nodules * Areas of fibrosis * Multiple resections of papillomas and tracheostomies
Trachobronchial papillomatosis
65
Cystic lung disease associated with * Few cysts or centrolobular nodules * Bilateral reticular opacities, lower lobe predominant * Septal thickening * Middle aged women * Hx of CVD, HIV, or CVID
LIP
66
Cystic lung disease associated with * Nodules predominantly * Mediastinal adenopathy * Plasma cell dyscrasias * Ig deposition in kidneys, heart, and liver
Light chain deposition disease
67
Cystic lung disease associated with * Nodules primarily * Sjogren's syndrome * GGO * Nodules are lower lobe predominant
Amyloidosis
68
Cystic lung disease associated with * Upper and middle lobe nodules * Variable size nodules that are bizarre shapes * Spares costophrenic angles
PLCH